WA
CNMD icon

Wasatch Advisors’s CONMED CNMD Stock Holding History

Wasatch Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-574,896
Closed -$23.3M – 219
2025
Q4 		$23.3M Sell
574,896
-425,028
-43% -$18.5M 0.14% 118
2025
Q3 		$47M Buy
+999,924
New +$51.8M 0.25% 95

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Wasatch Advisors's CNMD Position: Q1 2026 in Review

Wasatch Advisors sold out of CONMED (CNMD) in Q1 2026, closing a stake of 574,896 shares — an estimated $23.3M sold.

Wasatch Advisors first reported a position in CNMD in Q3 2025 and held it in 2 quarters. The position peaked at $47M in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Wasatch Advisors reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Wasatch Advisors sold 574,896 CONMED shares in Q1 2026, an estimated $23.3M.
  • Wasatch Advisors first reported a position in CONMED in Q3 2025 and held it in 2 quarters.
  • Wasatch Advisors's CONMED position peaked at $47M in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Wasatch Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.